mifepristone
PubChem Notes:
Mifepristone A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
MediLexicon mifepristone - Medical Dictionary Definition for Term 'mifepristone'
[1. Synthetic chemical compound with antiprogesterone properties used for early pregnancy termination; the substance binds with glucocorticoid receptors resulting in increased adrenal gland secretion.
Molecular Formula:
C29H35NO2
InChI: InChI=1/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
InChIKey: InChIKey=VKHAHZOOUSRJNA-GCNJZUOMBS
SMILES: CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O
Names:
mifepristone
Prestwick_570
(8S,11R,13S,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
84371-65-3
Registries:
PubChem CID 55245
PubChem ID 10321543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|